Global, regional and national burden of liver cancer 1990–2021: a systematic analysis of the global burden of disease study 2021.

Authors: Jiang, Zhichao¹ (AUTHOR), Zeng, Guoqiang² (AUTHOR), Dai, Huajia¹ (AUTHOR), Bian, Yuhao¹ (AUTHOR), Wang, Libin¹ (AUTHOR), Cao, Wei¹ (AUTHOR), Yang, Junfeng¹ (AUTHOR) richyjf@usst.edu.cn

Source: BMC Public Health. 3/8/2025, Vol. 25 Issue 1, p1-21. 21p.

Subject Terms: *GLOBAL burden of disease, *LIVER cancer, *PUBLIC health, *HOSPITAL admission & discharge, *MEDICAL sciences, CAUSE of death statistics

MCT4: a key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment.

Authors: Jiang, Tao^1,2 (AUTHOR), Zhang, Jingcheng^1,2 (AUTHOR), Zhao, Sicheng^1,2 (AUTHOR), Zhang, Mingsi³ (AUTHOR), Wei, Yunhai⁴ (AUTHOR), Liu, Xiaojuan^1,2 (AUTHOR), Zhang, Shuo^1,2 (AUTHOR), Fan, Wei^1,2 (AUTHOR), Liu, Yueying^1,2 (AUTHOR), Lv, Yuanlin¹ (AUTHOR) lvyuanlin99@163.com, Zhang, Guangji^1,2 (AUTHOR) zgjtcm@zcmu.edu.cn

Source: Journal of Translational Medicine. 3/5/2025, Vol. 23 Issue 1, p1-16. 16p.

Subject Terms: *LIVER cancer, *STOMACH cancer, *CANCER cell migration, *LIVER metastasis, *MEDICAL sciences

Pseudomonas aeruginosa -Mannose Sensitive Hemagglutinin-based Treatment Strategy for Liver Cancer.

Authors: Li, Lan¹ (AUTHOR), Yin, Lina¹ (AUTHOR), Shi, Jia¹ (AUTHOR), Zheng, Li¹ (AUTHOR), Min, Liu¹ (AUTHOR), Wu, Xiaoling¹ (AUTHOR) ylna2023@sina.com

Source: Pharmacognosy Magazine. Mar2025, Vol. 21 Issue 1, p81-88. 8p.

Subject Terms: *CANCER cell proliferation, *LIVER cancer, *LIVER cells, *PROTEIN expression, *PSEUDOMONAS aeruginosa

Association Between Dietary Inflammatory Potential and Liver Cancer Risk: A Systematic Review and Dose-Response Meta-Analysis.

Authors: Yang, Kun¹ (AUTHOR), Song, Xiaoru¹ (AUTHOR), Cheng, Cheng¹ (AUTHOR), Shi, Qianqian¹ (AUTHOR), Li, Xiaoyu¹ (AUTHOR), Long, Jinzhao¹ (AUTHOR), Yang, Haiyan¹ (AUTHOR), Chen, Shuaiyin¹ (AUTHOR) sychen@zzu.edu.cn

Source: Nutrition & Cancer. Feb2025, p1-11. 11p. 4 Illustrations.

Subject Terms: *LIVER cancer, *DIETARY patterns, *SCIENCE databases, *DISEASE risk factors, *NUTRITION policy

Big data analysis of influenza vaccination and liver cancer risk in hypertensive patients: insights from a nationwide population-based cohort study.

Authors: Chiu, Chun-Chih^1,2 (AUTHOR), Hao, Wen-Rui^1,2,3,4 (AUTHOR), Lin, Kuan-Jie^2,5 (AUTHOR), Chen, Chun-Chao^1,2,3,4 (AUTHOR), Yang, Tsung-Yeh^1,2 (AUTHOR), Fang, Yu-Ann^1,2 (AUTHOR), Yang, Tsung-Lin^2,3,6 (AUTHOR), Lai, Yu-Hsin^7,8,9 (AUTHOR), Chen, Ming-Yao^7,8,9 (AUTHOR), Hsu, Min-Huei^10,11 (AUTHOR), Lin, Cheng-Hsin^2,5 (AUTHOR), Hsiu, Hsin¹² (AUTHOR), Chen, Huan-Yuan¹³ (AUTHOR), Cheng, Tzu-Hurng¹⁴ (AUTHOR), Chen, Nai-Hsuan¹⁵ (AUTHOR) b101104098@tmu.edu.tw, Liu, Ju-Chi^1,2,3 (AUTHOR) liumdcv@tmu.edu.tw

Source: BMC Gastroenterology. 2/24/2025, Vol. 25 Issue 1, p1-11. 11p.

Subject Terms: *INFLUENZA vaccines, *LIVER cancer, *CANCER vaccines, *HYPERTENSION, *DISEASE risk factors

Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Authors: Tang, Lixuan¹ (AUTHOR), Yang, Xiao² (AUTHOR), He, Liwen¹ (AUTHOR), Zhu, Chaogeng³ (AUTHOR) 8193688@qq.com, Chen, Qingshan³ (AUTHOR) s_mountain@126.com

Source: Lipids in Health & Disease. 2/21/2025, Vol. 24 Issue 1, p1-22. 22p.

Subject Terms: *LIVER cancer, *MEDICAL sciences, *MEDICAL research, *HEPATOCELLULAR carcinoma, *DRUG resistance, *RADIOTHERAPY safety, *PHOTOTHERMAL effect

Risk Reduction of Intrahepatic Abscess After Locoregional Therapy for Liver Cancer in Patients with Prior Hepatobiliary Intervention.

Authors: Rudnick, Peter¹ (AUTHOR) prr43486@creighton.edu, Feia, Kaleb² (AUTHOR) kaleb-feia@uiowa.edu, Laeseke, Paul³ (AUTHOR) plaeseke@wisc.edu, Herman, Joseph⁴ (AUTHOR) jherman1@northwell.edu, Geschwind, Jeff⁵ (AUTHOR) jgeschwind@usaclinics.com

Source: Diagnostics (2075-4418). Feb2025, Vol. 15 Issue 3, p333. 9p.

Subject Terms: *LIVER abscesses, *LIVER cancer, *ANTIBIOTIC prophylaxis, *CANCER patients, *THERAPEUTIC complications

MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.

Authors: Bębenek, Wiktoria^1,2 (AUTHOR) wiktoria.bebenek@edu.uni.lodz.pl, Gajek, Arkadiusz¹ (AUTHOR) arkadiusz.gajek@biol.uni.lodz.pl, Marczak, Agnieszka¹ (AUTHOR) agnieszka.marczak@biol.uni.lodz.pl, Malý, Jan³ (AUTHOR) jan.maly@ujep.cz, Smejkal, Jiří³ (AUTHOR) jiri.smejkal@ujep.cz, Statkiewicz, Małgorzata⁴ (AUTHOR) malgorzata.statkiewicz@pib-nio.pl, Rusetska, Natalia⁵ (AUTHOR) natalia.rusetska@pib-nio.pl, Bryś, Magdalena⁶ (AUTHOR) magdalena.brys@biol.uni.lodz.pl, Rogalska, Aneta¹ (AUTHOR) aneta.rogalska@biol.uni.lodz.pl

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 2, p834. 21p.

Subject Terms: *CHECKPOINT kinase 1, *LIVER cancer, *HEPATOCELLULAR carcinoma, *THERAPEUTICS, *OVARIAN cancer

Anti-Tumor Effects of Vespa bicolor Venom on Liver Cancer: In Vitro and In Vivo Studies.

Authors: Wu, Yong-Hua¹ (AUTHOR) wuyh276@mail2.sysu.edu.cn, Xiong, Feng¹ (AUTHOR) xiongf35@mail.sysu.edu.cn, Ou, Zheng-Wen² (AUTHOR) 1ozw@163.com, Wang, Jing-An² (AUTHOR) kefu@hufenghuang.com, Cui, Jing² (AUTHOR) m18985140962@163.com, Jiang, Lin¹ (AUTHOR) jiangln@mail.sysu.edu.cn, Lan, Wen-Jian¹ (AUTHOR) jiangln@mail.sysu.edu.cn

Source: Toxins. Jan2025, Vol. 17 Issue 1, p4. 13p.

Subject Terms: *LIVER cells, *LIVER cancer, *VENOM, *CELL proliferation, *CELL growth

Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites.

Authors: Viperino, Alessandra¹ (AUTHOR) alessandra.viperino@charite.de, Höpfner, Michael¹ (AUTHOR) michael.hoepfner@charite.de, Edel, Nicole¹ (AUTHOR) nicole-edel@t-online.de, Al Nasr, Ibrahim S.² (AUTHOR) insar@qu.edu.sa, Koko, Waleed S.² (AUTHOR) wasyko2002@yahoo.com, Khan, Tariq A.³ (AUTHOR) sirtariqayub@gmail.com, Ben Abdelmalek, Imen² (AUTHOR) mm.abdulmalek@qu.edu.sa, Schobert, Rainer⁴ (AUTHOR) rainer.schobert@uni-bayreuth.de, Biersack, Bernhard⁴ (AUTHOR) bernhard.biersack@yahoo.com, Nitzsche, Bianca¹ (AUTHOR) bernhard.biersack@yahoo.com

Source: Pharmaceuticals (14248247). Jan2025, Vol. 18 Issue 1, p50. 16p.

Subject Terms: *PROTOZOAN diseases, *LIVER cancer, *LIVER cells, *TOXOPLASMA gondii, *ANTIPARASITIC agents

Animal-based radiation absorbed dose evaluation of holmium-166 labeled hydroxyapatite particulates in liver malignancies.

Authors: Bagheri, Reza¹ reza_bagheri@aut.ac.ir, Ranjbar, Hassan²

Source: Asia Oceania Journal of Nuclear Medicine & Biology. Jan2025, Vol. 13 Issue 1, p94-101. 8p.

Subject Terms: *LABORATORY rats, *LIVER cancer, *ABSORBED dose, *RADIOLABELING, *RADIATION doses

Molecular dynamics simulation based prediction of T-cell epitopes for the production of effector molecules for liver cancer immunotherapy.

Authors: Zafar, Sidra¹ (AUTHOR), Bai, Yuhe² (AUTHOR), Muhammad, Syed Aun¹ (AUTHOR) aunmuhammad78@yahoo.com, Guo, Jinlei³ (AUTHOR), Khurram, Haris^4,5 (AUTHOR), Zafar, Saba⁶ (AUTHOR), Muqaddas, Iraj¹ (AUTHOR), Shaikh, Rehan Sadiq⁷ (AUTHOR), Bai, Baogang^8,9,10 (AUTHOR) 20190165@wzbc.edu.cn

Source: PLoS ONE. 1/3/2025, Vol. 20 Issue 1, p1-32. 32p.

Subject Terms: *ESCHERICHIA coli, *LIVER cancer, *MOLECULAR dynamics, *BINDING energy, *MACHINE learning

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer.

Authors: Bae, Sarah Da Won¹ (AUTHOR), Nguyen, Romario¹ (AUTHOR), Yuen, Lawrence² (AUTHOR), Lam, Vincent² (AUTHOR), George, Jacob^1,3 (AUTHOR) jacob.george@sydney.edu.au, Qiao, Liang¹ (AUTHOR) liang.qiao@sydney.edu.au

Source: Scientific Reports. 12/28/2024, Vol. 14 Issue 1, p1-9. 9p.

Subject Terms: *CANCER stem cells, *LIVER cancer, *ANDROSTANE receptors, *HEPATOCELLULAR carcinoma, *MEDICAL sciences

Construction of reusable fluorescent assembled 3D-printed hydrogen-based models to simulate minimally invasive resection of complex liver cancer.

Authors: Cao, Wenli^1,2 (AUTHOR), Pan, Xiaofeng³ (AUTHOR), Jin, Liming¹ (AUTHOR), Liu, Jie¹ (AUTHOR), Cao, Jie⁴ (AUTHOR), Jin, Lei^1,5 (AUTHOR), Wei, Fangqiang¹ (AUTHOR) wdfwfq@126.com

Source: PLoS ONE. 12/27/2024, Vol. 19 Issue 12, p1-13. 13p.

Subject Terms: *LIVER cancer, *LIVER surgery, *SURGICAL education, *CLINICAL medicine, *FLUORESCENCE

Liver resection for breast cancer-related liver metastases: a case report.

Authors: Pangarsa, Eko Adhi¹ (AUTHOR) ekopangarsa90@gmail.com, Prabowo, Erik² (AUTHOR) erikprabowo@fk.undip.ac.id, Subiyakto³ (AUTHOR) subiyaktobustomi@gmail.com, Yudisaputro, Wasisto Dwi³ (AUTHOR) dputro80@gmail.com, Istiadi, Hermawan⁴ (AUTHOR) hermawanistiadi@fk.undip.ac.id, Hadiyanto, Jessica Novia⁵ (AUTHOR) odiliajessicanovia@gmail.com, Tandarto, Kevin⁵ (AUTHOR) tandartok@gmail.com, Rizky, Daniel¹ (AUTHOR) danielrizky@hotmail.co.id, Setiawan, Budi¹ (AUTHOR) boedhi_73@gmail.com, Santosa, Damai¹ (AUTHOR) santosaivha@fk.undip.ac.id, Suharti, Catharina¹ (AUTHOR) hemasemarang@gmail.com

Source: Journal of Medical Case Reports. 12/23/2024, Vol. 18 Issue 1, p1-6. 6p.

Subject Terms: *LIVER metastasis, *LIVER cancer, *MEDICAL sciences, *PROGNOSIS, *PROGESTERONE receptors

Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma.

Authors: Huang, Tengda¹ (AUTHOR), Chen, Hongying² (AUTHOR), Pan, Hongyuan¹ (AUTHOR), Wu, Tian³ (AUTHOR), Ren, Xiangyi⁴ (AUTHOR), Qin, Liwen⁴ (AUTHOR), Yuan, Kefei¹ (AUTHOR) ykf13@163.com, He, Fang⁴ (AUTHOR) fanghe923@hotmail.com

Source: PLoS ONE. 12/13/2024, Vol. 19 Issue 12, p1-15. 15p.

Subject Terms: *LIVER cancer, *HEPATOCELLULAR carcinoma, *GENE expression, *MICROFILAMENT proteins, *CANCER-related mortality

Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from Nanog -Overexpressing Colon-26 Cancer Cells.

Authors: Henmi, Takuya¹ (AUTHOR), Matsuoka, Hideaki² (AUTHOR), Katayama, Noa¹ (AUTHOR), Saito, Mikako^1,2 (AUTHOR) mikako@cc.tuat.ac.jp

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12794. 19p.

Subject Terms: *NON-coding RNA, *LIVER cancer, *EXTRACELLULAR vesicles, *COLON cancer, *CANCER cells

Structure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers.

Authors: Morcos, Christine A.¹ (AUTHOR), Haiba, Nesreen S.² (AUTHOR), Bassily, Rafik W.¹ (AUTHOR), Abu-Serie, Marwa M.³ (AUTHOR), El-Yazbi, Amira F.⁴ (AUTHOR), Soliman, Omar A.⁵ (AUTHOR), Khattab, Sherine N.¹ (AUTHOR) sherinekhattab@alexu.edu.eg, Teleb, Mohamed^6,7 (AUTHOR) mohamed.t.ismail@alexu.edu.eg

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2024, Vol. 39 Issue 1, p1-31. 31p.

Subject Terms: *MOLECULAR structure, *LIVER cancer, *DNA damage, *MOLECULAR dynamics, *MATRIX metalloproteinases

Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations.

Authors: Jin, Xing¹ (AUTHOR), Wang, Yuting² (AUTHOR), Chen, Jing¹ (AUTHOR), Niu, Miaomiao² (AUTHOR), Yang, Yang¹ (AUTHOR), Zhang, Qiaoxuan^3,4 (AUTHOR) zhangqiaoxuan123@163.com, Bao, Guangyu¹ (AUTHOR) ydfygyb3509@163.com

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2024, Vol. 39 Issue 1, p1-13. 13p.

Subject Terms: *VIRTUAL high-throughput screening (Drug development), *LIVER cancer, *MOLECULAR dynamics, *HISTONE deacetylase, *HISTONE methylation

Inhibition of TFAM-Mediated Mitophagy by Oroxylin A Restored Sorafenib Sensitivity Under Hypoxia Conditions in HepG2 Cells.

Authors: Ji, Shufan¹ (AUTHOR) 20210821@njucm.edu.cn, Xu, Xuefen^1,2 (AUTHOR) 460103@njucm.edu.cn, Li, Yujia¹ (AUTHOR) 18260028677@163.com, Sun, Sumin¹ (AUTHOR) 18861013911@163.com, Fu, Qiuyu¹ (AUTHOR) dgdfqy521@163.com, Qiu, Yangling¹ (AUTHOR) ylqiu720@163.com, Wang, Shuqi¹ (AUTHOR) 15765339936@163.com, Xia, Siwei¹ (AUTHOR) 20223116@njucm.edu.cn, Wang, Feixia¹ (AUTHOR) 300585@njucm.edu.cn, Zhang, Feng¹ (AUTHOR) zhangfeng2013@njucm.edu.cn, Xuan, Ji³ (AUTHOR) helio0009@126.com, Zheng, Shizhong¹ (AUTHOR) helio0009@126.com

Source: Pharmaceuticals (14248247). Dec2024, Vol. 17 Issue 12, p1727. 18p.

Subject Terms: *TRANSCRIPTION factors, *LIVER cancer, *CANCER treatment, *TREATMENT effectiveness, *MOLECULAR docking